lapatinib

Ligand id: 5692

Name: lapatinib

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: lapatinib

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 11
Topological polar surface area 114.73
Molecular weight 580.13
XLogP 6.04
No. Lipinski's rules broken 2

Molecular properties generated using the CDK

Classification
Compound class Synthetic organic
Approved drug? Yes (FDA (2007), EMA (2008))
IUPAC Name
N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(5-{[(2-methanesulfonylethyl)amino]methyl}furan-2-yl)quinazolin-4-amine
International Nonproprietary Names
INN number INN
8378 lapatinib
Synonyms
FMM | GW 572016 | GW572016 | Tykerb® | Tyverb®
Database Links
CAS Registry No. 231277-92-2
ChEMBL Ligand CHEMBL554
DrugBank Ligand DB01259
PubChem CID 208908
RCSB PDB Ligand FMM
Search Google for chemical match using the InChIKey BCFGMOOMADDAQU-UHFFFAOYSA-N
Search Google for chemicals with the same backbone BCFGMOOMADDAQU
Search PubMed clinical trials lapatinib
Search PubMed titles lapatinib
Search PubMed titles/abstracts lapatinib
Search UniChem for chemical match using the InChIKey BCFGMOOMADDAQU-UHFFFAOYSA-N
Search UniChem for chemicals with the same backbone BCFGMOOMADDAQU
Wikipedia Lapatinib
Comments
Lapatinib is a Type-1.5 kinase inhibitor and was first approved by the US FDA in 2007.